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Abstract
Small Rho GTPases are well known to regulate a variety of cellular processes by acting as molecular switches. The regulatory
function of Rho GTPases is critically dependent on their posttranslational modification at the carboxyl terminus by
isoprenylation and association with proper cellular membranes. Despite numerous studies, the mechanisms of recycling and
functional integration of Rho GTPases at the biological membranes are largely unclear. In this study, prenylated human
Rac1, a prominent member of the Rho family, was purified in large amount from baculovirus-infected Spodoptera frugiperda
insect cells using a systematic detergent screening. In contrast to non-prenylated human Rac1 purified from Escherichia coli,
prenylated Rac1 from insect cells was able to associate with synthetic liposomes and to bind Rho-specific guanine
nucleotide dissociation inhibitor 1 (GDI1). Subsequent liposome reconstitution experiments revealed that GDI1 efficiently
extracts Rac1 from liposomes preferentially in the inactive GDP-bound state. The extraction was prevented when Rac1 was
activated to its GTP-bound state by Rac-specific guanine nucleotide exchange factors (GEFs), such as Vav2, Dbl, Tiam1, P-
Rex1 and TrioN, and bound by the downstream effector Pak1. We found that dissociation of Rac1-GDP from its complex
with GDI1 strongly correlated with two distinct activities of especially Dbl and Tiam1, including liposome association and
the GDP/GTP exchange. Taken together, our results provided first detailed insights into the advantages of the in vitro
liposome-based reconstitution system to study both the integration of the signal transducing protein complexes and the
mechanisms of regulation and signaling of small GTPases at biological membranes.
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Introduction
The Rho family GTPases are known to play an important role
in diverse cellular processes and progression of different diseases,
such as cardiovascular diseases, developmental and neurological
disorders, as well as in tumor invasion and metastasis [1]. Rho
GTPases share two common functional characteristics, membrane
anchorage and an on/off switch cycle [2,3].
Subcellular localization of Rho GTPases to different cellular
membranes is known to be critical for their biological activity. This
is achieved by a hypervariable region (HVR) [4] and a lipid
anchor in their C-terminal tail at a distinct cysteine residue in the
CAAX motif (C is cysteine, A is any aliphatic amino acid, and X is
any amino acid) [2,5,6,7]. In addition to either geranylgeranyla-
tion or farnesylation at the CAAX motif, some members of the
Rho family, such as Rac1, require the C-terminal polybasic region
and palmitoylation, essential for plasma membrane targeting and
interaction with multiple lipids [8,9].
Rho GTPase function is dependent on the guanine nucleotide-
binding (G) domain that contains the principle binding center for
GDP and GTP and binds depending on its nucleotide-bound state
various regulators and effectors [3]. Thus, membrane-associated
Rho GTPases act, with some exceptions [10], as molecular
switches by cycling between an inactive GDP-bound state and an
active GTP-bound state [10]. This cycle underlies two critical
intrinsic functions, the GDP-GTP exchange and GTP hydrolysis
[10] and is controlled by at least three classes of regulatory proteins
[3]: (i) Guanine nucleotide exchange factors (GEFs), especially
those of the diffuse B-cell lymphoma (Dbl) family, which catalyze
the exchange of GDP to GTP and activate the GTPase [11,12]; ii)
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GTPase activating proteins (GAPs), which enhance the GTP
hydrolysis and convey the GTPase in its inactive conformation
[13,14]; (iii) Guanine nucleotide dissociation inhibitors (GDIs),
which bind to prenylated Rho GTPases and extract them from the
membranes into the cytoplasm [15,16,17]. The formation of the
active GTP-bound state of Rho GTPases is accompanied by a
conformational change in two regions (known as switch I and II;
[3] which provide a platform for the selective interaction with
structurally and functionally diverse effectors, e.g. p21-activated
kinase a (Pak1). This class of proteins activate a wide variety of
downstream signaling cascades [18,19,20] thereby regulating
many important physiological and pathophysiological processes
in eukaryotic cells [21,22].
The last decades in research of small GTPases under cell-free
conditions were prevalently dominated by non-membranous
systems such as soluble, mostly C-terminally truncated GTPases
as well as shortened regulatory and effector proteins, mostly
comprised of either the minimal catalytically active regulatory
domains (GAPs, GEFs) or, in the case of effectors, the GTPase-
binding domains (GBDs). Since the basic molecular mechanism
of GTPase regulation and effector interaction is largely elucidat-
ed, it is in fact necessary now to move from these simplified
soluble systems to more physiological and complex systems, i.e.
multi-domain binding proteins acting on prenylated GTPases
bound to the lipid membranes, the site at which they normally
achieve their function in cells. A crucial prerequisite is, therefore,
the availability of large quantities of purified, posttranslationally
modified GTPases. Several different strategies have been
developed to obtain lipid-modified proteins. It has been shown
that Cdc42 purified from human platelets and insect cells can be
extracted from the liposomes by RhoGDI1 (called here GDI1)
[23,24]. Rac1 alone was purified from insect cells by using
detergents [25,26]. Robbe et al. have purified prenylated Rac1 in
complex with GDI1 that stabilized Rac1 in aqueous solution
[27,28]. A similar strategy was used for the purification and
structural determination of the Cdc42?GDP?GDI1 complex as
well as of RhoA [29,30]. Ugolev et al. have used an enzymatic
method to modify Rac1 in vitro by using geranylgeranyl
transferase I [31]. They have shown that Rac1 dissociated from
GDI1 by the cooperative action of RacGEFs and phosphatidy-
linositol (3, 4, 5)-trisphosphate (PIP3) containing liposomes.
Gureasko et al. have directly attached Ras covalently to liposomes
by using chemical cross linking [32]. The latter strategy avoids
difficulties inherent in purifying lipid-modified proteins but is not
useful for extraction experiments of membrane-bound GTPases
using GDIs [27] or, alternatively, the d subunit of phosphodies-
terase (PDEd) [33,34,35]. A large number of studies have utilized
the advantage of a chemical ligation of a synthesized, lipidated C-
terminal peptide with the purified G domain of different small
GTPases [36], such as Rab proteins [37,38,39], K-Ras [35] and
RhoA [17]. However, the question of how naturally modified,
liposome-bound small GTPases, e.g. Rac1, interact with their
regulators and effectors remains to be unveiled.
In this study we established a novel protocol for the extraction
and purification of recombinant, prenylated, functionally active
human Rac1 using a baculovirus-insect cell expression system
and a detergent screening. Subsequently, in vitro liposome
reconstitution studies were performed to gain insights into the
Rac1 association with liposomes of different lipid compositions,
and the extraction of Rac1 by GDI1. Rac1 extraction was
prevented by a GEF-mediated Rac1 activation and Pak1
interaction.
Materials and Methods
Constructs
Human Rac1 (GenBank accession no. NM_006908.4) was
subcloned into pFastBacHTB vector (Invitrogen, Carlsbad, CA)
and fused with an N-terminal hexa-histidine (6xHis) tag. For
bacterial expression, full-length Rac1 and GDI1 (GenBank
accession no. D13989) were cloned into pGEX-4T1 vector.
DHPH constructs of human Vav2 (aa 168–543), human Dbl (aa
498–825), TrioN (aa 1226–1535), murine Tiam1 (aa 1033–1404),
human P-Rex1 (aa 34–415), and human Pak1-GBD (aa 57–141)
have been reported before [11,40].
Antibodies, media and reagents
Anti-His-tag (mouse), anti-Rac (mouse), anti-E-cadherin (rab-
bit), anti-GAPDH (rabbit), anti-histone H3 (rabbit), anti-a-tubulin
(rabbit), anti-rabbit IgG (goat), anti-mouse IgG conjugated with
Alexa FluorH 488 (goat), anti-Rabbit IgG conjugated with Alexa
FluorH 594 (goat) were purchased from Invitrogen (Oregon, USA);
anti-mouse IgG was obtained from Dako (rabbit, California,
USA). GDP and a non-hydrolyzable GTP analogue, guanosine 59-
[b,c-imido]triphosphate (GppNHp), were obtained from Jena
Bioscience GmbH (Jena, Germany). TC100 insect cell media, fetal
bovine serum, antibiotics (penicillin and streptomycin) and 10%
Pluronic F-68 were obtained from PAN-Biotech GmbH (Aiden-
bach, Germany). Phosphatidylserine (PS), Phosphatidylcholine
(PC), phosphatidylethanolamine (PE) and sphingomyelin (SM),
phosphatidylinositol 4,5-bisphosphate (PIP2), and Folch I and
Folch III brain lipid extracts were purchased from Sigma-Aldrich
(Munich, Germany). PIP3 is from Merck (Darmstadt, Germany).
All other standard reagents, including detergents (Table S1 in File
S1) were obtained from Carl Roth GmbH (Karlsruhe, Germany)
or Merck-Millipore (Darmstadt, Germany).
Baculoviruses and insect cell culture
Human Rac1 gene subcloned into pFastBacHTB vector
(Invitrogen, Carlsbad, CA) was transformed into DH10BAC
strain. Agar plates containing kanamycin, gentamycin, tetracy-
cline, X-gal and isopropyl-b-D-thiogalactoside were used to select
recombinant Rac1 clones. The Rac1-positive clones underwent
two more purification steps before recombinant Rac1 bacmid
were extracted. The baculoviruses (passage 1) were generated by
infecting Sf9 insect cells using recombinant Rac1 bacmids. Viruses
were ready to use for large scale Rac1 expression after two more
amplification steps (passages 2 and 3).
Sf9 were cultured in TC-100 medium, containing 10% fetal
bovine serum, penicillin, streptomycin and pluronic F-68 solution
at 27uC. The titer of baculoviruses was determined by the ITCD50
method [41,42]. The multiplicity of infection (MOI) and Rac1
expression time were optimized by infecting the Sf9 cells at
different MOIs and different culture time points. Samples of
infected cells (1 ml) were harvested; the cell pellets were lysed in
Laemmli buffer, containing 60 mM Tris-HCl pH 6.8, 2% SDS,
10% glycerol, 5% b-mercaptoethanol, 0.01% bromophenol blue
and analyzed by immunoblotting using an anti-His-tag antibody.
Confocal laser scanning microscopy (cLSM)
Insect cells were fixed with acetone/methanol (1:1) at 24 hours
after seeding in 12 well plates. Cells were incubated first with
antibodies against Rac1 and a-tubulin and then with secondary
anti-mouse and anti-rabbit antibodies conjugated with Alexa
FluorH 488 and Alexa FluorH 594 as well as DAPI (Danvers, USA).
All steps were carried out at room temperature. Specimens were
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visualized and photographed using a confocal laser scanning
microscope (LSM510META; Zeiss, Jena, Germany).
Cell fractionation
Sf9 cells were harvested, resuspended in a buffer, containing
10 mM HEPES-NaOH pH 7.9, 1.5 mM MgCl2, 10 mM KCl,
0.5 mM dithiothreitol (DTT), 1 tablet EDTA-free protease
inhibitors (Roche, Mannheim, Germany), and disrupted under
detergent-free conditions using pre-chilled Dounce homogenizer
for 20 strokes with a tight pestle. Disrupted cells were centrifuged
at 300xg for 5 min at 4uC. The supernatant was removed and
centrifuged at 50000xg for 2 h at 4uC to separate the membrane
(pellet) and the cytosolic fractions (supernatant). The pellet,
containing enriched nuclei, was resuspended in 0.25 mM sucrose,
10 mM MgCl2 and a cushion of 0.88 mM sucrose and 0.5 mM
MgCl2 was laid over. This sample was centrifuged at 2800xg for
10 min at 4uC to obtain the nuclear pellet. Protein samples from
different fractions were analyzed by immunoblotting. Anti-Rac1
antibody was used to detect distribution of recombinant human
Rac1 in all the fractions. Antibodies against E-cadherin, GAPDH
and Histone H3 were used as marker for membrane, cytoplasmic
and nuclear fractions, respectively.
Detergent screening
Eighteen different detergents (Table S1 in File S1) were used to
extract Rac1 from the membrane fraction of Sf9 insect cells.
Detergents were used at 20% (w/v) stock solution in buffer,
containing 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 2 mM
MgCl2, 10% glycerol, 20 mM b-glycerolphosphate, 1 mM ortho-
Na3VO4 and 1 tablet EDTA-free inhibitor cocktail. The
detergents at 1% and 0.5% (w/v) final concentrations were added
into the suspension of membrane fractions, containing recombi-
nant human Rac1. The mixtures were incubated at room
temperature for 30 min and centrifuged at 20000xg for 10 min.
The pellets and small amounts of supernatants were collected for
immunoblot analysis. Residual supernatants were used further for
pull-down assays with glutathione S-transferase (GST)-GDI1.
Thin layer chromatography
To check the lipid composition of the liposomes thin-layer
chromatography was conducted using a thin layer chromatogra-
phy plate (silica, 20620 cm; Macherey-Nagel GmbH, Du¨ren,
Germany) and a chloroform/methanol/water/acetic acid
(60:50:4:1) as eluting solvent system. Lipids were detected by
molybdophosphoric acid spray.
Protein purification and nucleotide exchange
Large scale Rac1 expression was conducted according to the
established protocol described above. Sf9 insect cells were
inoculated at a density of 1.56106 cells/ml under optimized
MOI and culture time. Cells were resuspended in lysis buffer,
containing 50 mM HEPES-NaOH pH 7.4, 150 mM NaCl,
2 mM b-mercaptoethanol, 5 mM MgCl2, 0.1 mM GDP,
10 mM imidazole and the optimized detergents according to the
screening procedure described above. Cells were disrupted by
sonication in ice-water mixture. Supernatants were collected by
centrifugation and loaded on a Ni-NTA Superflow column
(Qiagen, Hilden, Germany). High salt buffer (50 mM HEPES-
NaOH pH 7.4, 150 mM NaCl, 2 mM b-mercaptoethanol, 5 mM
MgCl2, 0.1 mM GDP, 10 mM imidazole, 350 mM KCl and
1 mM ATP) was used to remove impurities from the target
proteins. Rac1 protein was eluted using an imidazole gradient
ranging from 10 to 500 mM. The protein solution was concen-
trated and further purified on a Superdex 75 column (10/300 GL,
GE-Healthcare, Uppsala, Sweden) with 50 mM HEPES-NaOH
pH 7.4, 150 mM NaCl, 3 mM DTT, 5 mMMgCl2 and 0.5% (w/
v) Na-cholate as buffer system. GppNHp-bound Rac1 proteins as
well as human GDI1, RacGEFs, Pak1, full length and C-terminal
truncated Rac1 proteins were prepared from E. coli as described
previously [11,43].
Pull-down assay
GST-fused human GDI1 bound to glutathione beads was used
to pull-down prenylated Rac1 from supernatants in the detergent
screening procedure. Because of a detergent-induced nucleotide
depletion of Rac1 it was important to determine the content of
GDP-bound Rac1 proteins. The respective supernatants and
beads were mixed and rotated at 4uC for 30 min. Samples were
centrifuged at 500xg for 30 sec. Beads were washed three times
using the buffers described above and containing the correspond-
ing detergents. The beads and supernatant were analyzed by
immunoblotting using anti-Rac antibody.
Liposome preparation
Liposome assays were performed by mixing and incubating the
liposomes and purified Rac1 proteins. The mixtures were
incubated for different time points and centrifuged at different
speeds to separate the liposome pellets and supernatants for
optimizing the centrifuging force. The liposomes were prepared as
described previously [44]. Briefly, a lipid mixture (194 mg),
containing 39% (w/w) PE, 16% (w/w) PC, 36% (w/w) PS, 4%
(w/w) SM, and 5% (w/w) PIP2 or PIP3, was dried using light
nitrogen stream. Obtained lipid film was hydrated with 300 ml of a
buffer, containing 30 mM HEPES-NaOH pH 7.4, 50 mM NaCl,
3 mM DTT, 5 mM MgCl2. Sonication (20 s with minimal power,
50% off and 50% on) was employed finally to form liposomes.
Folch I and Folch III brain lipids extracts were prepared in
methanol and chloroform at a concentration of 25 mg/ml. Folch I
contains different phosphoinositides, PS, and cerebrosides in a
ratio of 1:5:4 [45]. Folch III is composed of 80% PS, 10% PE, 5%
cerebrosides and 5% unidentified membrane lipids [46]. Folch I or
Folch III liposomes (250 mg, respectively) were prepared under the
same conditions in 300 ml of the HEPES buffer. Liposomes with
increasing PS or PC were prepared by either PS/PE or PC/PE to
analyze lipid composition of Folch III. PC was used as control.
Total lipids used for each liposome preparation were constantly
250 mg in 300 ml buffer.
Results
Subcellular localization of human Rac1 overexpressed in
insect cells
The baculovirus-Spodoptera frugiperda (Sf9) insect cell expres-
sion system was used to express and purify human Rac1 in a
prenylated form. In order to obtain optimal Rac1 expression, the
tissue culture infectious dose 50 (TCID50) method was utilized to
determine titers of the baculovirus stocks as described before
[41,42]. A striking characteristic of baculovirus-infected Sf9 cells is
the so-called cytopathic effect, which is observed as a reduction of
cell numbers and swollen cell size depending on the extent of
infection as compared to the non-infected, highly confluent culture
(Fig. S1A in File S1). Sf9 cells were next infected at different MOIs
and culture time length. Increasing amounts of baculovirus
resulted in a slight, dose-dependent increase in Rac1 expression
with a peak around 36 and 48 h post-infection, especially at a
MOI of 4 or 5 (Fig. S1B in File S1). Confocal imaging analysis
revealed that human Rac1 is predominantly localized at the
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plasma membrane (Fig. S1C in File S1). Cell fractionation
experiments showed that Rac1 was mainly found in the
membrane and endoplasmic reticulum-enriched nuclear fractions
(Fig. S1D in File S1). These data clearly show that human Rac1
produced in insect cells exhibits similar characteristics as
compared to endogenous Rac1 in mammalian cells, such as
mouse embryonic fibroblasts and HeLa [47], regarding its cellular
distribution [48].
Detergent extraction and purification of prenylated
human Rac1 overexpressed in insect cells
An important issue to be considered for the extraction of
nucleotide-bound, prenylated human Rac1 from Sf9 membrane
fractions was the choice of an appropriate detergent. First attempts
using deoxycholate and cholate as detergents were not successful.
The former did not solubilize Rac1, while the latter did extract
Rac1 but considerable amounts of extracted Rac1 proteins were
depleted of their bound nucleotide (data not shown) indicating
partial unfolding upon cholate treatment. It is of importance to
note that a stoichiometric ratio of bound GDP is mandatory to
avoid aggregation and precipitation of penylated Rac1, which
means that the GDP-bound state must be monitored at every
purification step, including detergent extraction from the cell
membrane. Therefore, we tested sixteen additional detergents
regarding their properties to extract fully functional Rac1 from the
insect cell membrane fractions (Table S1 in File S1). Considering
that the high amounts of detergent may also impair the quality of
proteins, we used two different detergent concentrations (0.5% and
1% (w/v), respectively). Figure 1A illustrates a workflow with the
corresponding steps of Rac1 extraction from the membrane and its
pull-down by GST-GDI1. Seven detergents, i.e. Triton X-100,
Triton X-114, Igepal CA 630, CHAPS, n-dodecyl-b-D-maltoside,
Zwittergent 3–12 and Zwittergent 3–14 extracted similar amounts
Rac1 from the membrane fraction at 0.5 and 1% concentrations
(see supernatant fractions S1 in Fig. 1B, upper panel). In contrast,
higher concentrations (1%) of cholate, n-octyl-b-D-glucopyrano-
side, n-nonyl-b-D-glucopyranoside, n-octyl-b-D-thioglucopyrano-
side, Zwittergent 3–10 and Zwittergent 3–16 were required to
quantitatively extract Rac1 (Fig. 1B, upper panel). Tween 20, n-
hexyl-b-D-glucopyranoside, n-heptyl-b-D-glucopyranoside and
Zwittergent 3-08 were not useful at any concentrations (see pellet
fractions P1 in Fig. 1B, upper panel).
After Rac1 was solubilized into the S1 fractions, purified GST
fusion protein GST-GDI1 was employed to assess the functionality
of soluble Rac1 in pull-down (PD) experiments, since only
prenylated and GDP-bound Rac1 proteins are useful to study
the RhoGDI interaction. From the seven detergents described
above, CHAPS at 0.5% revealed the best property in extracting
Rac1 from the insect cell membrane in its native, GDP-bound
state (see P2 in Fig. 1B, lower panel). Almost all Rac1 proteins
from the supernatant 1 (S1) were pulled down. In contrast,
considerable amounts of Rac1 extracted by the other six
detergents (Triton X-100, Triton X-114, Igepal CA 630, n-
dodecyl-b-D-maltoside, Zwittergent 3–12 and Zwittergent 3–14)
remained in the S2 fraction indicating that these Rac1 proteins are
nucleotide-depleted or in incorrect conformation and thus inactive
in binding to GST-GDI1 (Fig. 1B, lower panel).
Taken together, CHAPS displayed the two criteria required for
further studies, namely to quantitatively solubilize Rac1 from
insect cell membranes and to fully retain the GDI-binding activity
of Rac1. Accordingly, 0.5% CHAPS was used to extract Rac1
from the membrane before successively applying the protein
solution on two chromatography columns (Ni-NTA and size
exclusion, respectively), in order to purify human Rac1 from insect
cells (called from now Rac1Ic) at high quantities. Mass spectro-
metric analysis of intact Rac1Ic, compared to human Rac1 full
length purified from E. coli (Rac1Ec), revealed a fully modified
protein by geranylgeranylation with a modified most likely
phosphorylated population (Fig. S2 in File S1).
Human Rac1 purified from insect cells associates with
liposomes
To analyze the membrane-binding properties of Rac1Ic
synthetic liposomes were prepared and sedimentation experiments
were conducted according to the workflow illustrated in Figure
S3A in File S1. To setup Rac1Ic sedimentation by the liposomes
various conditions were tested and optimized. One aspect was the
incubation time after mixing Rac1Ic with liposomes. Under the
given conditions a weak binding of Rac1Ic to the liposomes was
observed, which was not significantly changed with increasing
incubation time (Fig. S3B in File S1). We next analyzed the
sedimentation force to avoid disruption of Rac1Ic-liposome
interactions by incubating the samples for 30 min and using
different centrifugation speeds to spin down the liposomes. Figure
S3C in File S1 shows that increasing sedimentation force from
20,000xg to 60,000xg led to dissociation of Rac1Ic from the
liposomes suggesting that the sedimentation force should not
exceed 20,000xg. In the next step we varied the ratio of Rac1
(1.5 mg) and liposomes (10 to 60 ml), and found out that as lower
the ratio of Rac1Ic to liposome is as larger are the Rac1Ic amounts
associated with the liposomes (Fig. S3D in File S1). The data
clearly indicate that mixing of 1.5 mg Rac1Ic with 20 ml liposomes
for 20 min and centrifuging the sample at 20,000xg for 30 min
provides optimal conditions for Rac1Ic sedimentation with
liposomes, which are used in following experiments.
The question of whether the lipid compositions of the liposomes
may affect the liposome association of Rac1Ic was next addressed
using the optimized conditions described above. Data shown in
Figure S3E in File S1 reveal that Rac1Ic-liposome interaction was
only marginally affected upon depletion of the liposomes by
individual phospholipids, especially PS and PIP2, by comparing
the amounts of Rac1Ic in the supernatants. As a control, we used
Rac1Ec, which does not bind to the liposomes at all (Fig. S3E in
File S1). Taken together, our data clearly demonstrate that Rac1Ic
is a lipidated protein and fulfills all criteria for the subsequent in
vitro liposome reconstitution analysis.
GDI1 interacts with and extracts Rac1Ic from liposomes
GDI1 is reported to solubilize Rac1 in living cells and inhibit
GDP dissociation from Rac1 [23], for which a C-terminal
geranylgeranylation of Rac1 is required [48]. Therefore, we
examined the properties of Rac1Ic interaction with liposomes and
GDI1 by combining liposome sedimentation and GST-GDI1 pull-
down assays. As controls, Rac1Ec was used. In addition, we
prepared also inactive GDP-bound and stable active GppNHp-
bound forms of the Rac1 proteins. GppNHp is a non-hydrolysable
analogue of GTP. As shown in Figure 2A, GST-GDI1 pulled
down only Rac1Ic but neither Rac1Ec. Data obtained from the
immunoblotting analysis of the supernatant and pellet fractions
after liposome sedimentation showed that equal amounts of Rac1Ic
in GDP-bound and GppNHp-bound states were associated with
the liposomes (Fig. 2B). Under these conditions, we did not
observe any liposome binding of Rac1Ec. Association of Rac1Ic,
but not Rac1Ec, with both GDI1 and liposomes clearly support the
mass spectrometric data and proved that human Rac1 purified
from insect cells is posttranslationally modified by geranylgerany-
lation.
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GDI1 is known to extract inactive, GDP-bound Rho GTPases,
such as Rac1, from membranes and hold them in a complex in the
cytosol away from their sites of action at membranes
[16,23,49,50]. To test this issue on liposomes in vitro in more
detail, we performed two types of experiments. In the first
approach, liposomes, GDI1 and Rac proteins were mixed together
and incubated for 20 min at room temperature. Subsequently, the
samples were centrifuged at 20,000xg for 30 min, and the
respective supernatants and liposome pellets were immunoblotted
using an anti-Rac antibody. The majority of the Rac1Ic proteins
remained in the supernatant most likely in complex with GDI1
regardless of the nature of the bound nucleotide (Fig. 2C). Only a
trace amount of Rac1Ic protein, especially the GppNHp-bound
form, was found in the liposome fraction. These data shows that
GDI1 dominantly competes with the liposomes in binding Rac1Ic.
In the second approach, we firstly prepared Rac1Ic-bound
liposomes under the same condition as in the previous experiment
but in the absence of GDI1, then mixed the sample with GDI1
and performed the liposome sedimentation experiment again.
Figure 2D shows that GDI1 is able to extract Rac1Ic from
liposomes preferentially in the GDP-bound from. To further prove
this observation we repeated these experiments using increasing
concentrations of GDI1 of 2- to 20-fold molar excess above
Rac1Ic, associated with liposomes. A 2-fold excess of GDI1 was
sufficient to displace all ‘‘extractable’’ GDP-bound Rac1Ic from
the liposomes (Fig. 2E). In contrast, about 10-fold larger amounts
of GDI1 were required to extract Rac1Ic-GppNHp from the
liposomes (Figs. 2E). Taken together, our result clearly demon-
strates that the majority of the membrane-bound Rac1 protein is
extracted by GDI1 and remains GDI1 associated.
Rac1Ic activation counteracts its extraction from the
liposomes by GDI1
We have shown above that GDI1 also binds Rac1Ic-GppNHp
and extracts it from the liposomes (Fig. 2). To examine the
interrelationship of this interaction, we conducted a series of
liposome sedimentation experiments in the presence of the
GTPase-binding domain (GBD) of Pak1 (called here Pak1).
Mixing the Rac1Ic proteins with liposomes, GDI1 and Pak1,
respectively, revealed that Pak1 did neither influence the
association of the GDP-bound Rac1Ic proteins with the liposomes
nor with GDI1 (Fig. 3A, lane 5). This data were comparable to the
conditions when GDI1 was present and Pak1 absent (Fig. 2C,
lane1). In contrast, Pak1 strongly counteracted a GDI1-mediated
displacement of GppNHp-bound Rac1Ic from the liposomes
(Fig. 2C, lane2 and Fig. 3A, lane 6). In the next experiments we
used liposome-associated Rac1Ic proteins and showed that GDI1
extracted Rac1Ic in both nucleotide-bound states from the
liposomes in the absence of Pak1 (Fig. 3B, lane 1 and 2). Addition
of Pak1 efficiently blocked GDI1-driven Rac1 extraction of
GppNHp-bound Rac1Ic from the liposomes (Fig. 3B, lane 4) but
not that of the GDP-bound Rac1Ic (Fig. 3B, lane 3). In agreement
with the structural data [3,28,51,52], our results suggest that Pak1
Figure 1. Detergent screening for optimal extraction of GDP-bound Rac1 from the insect cell membrane. (A) Schematic workflow for
the isolation of insect cell membrane fraction, detergent extraction and pull-down assay using GST-GDI1. (B) Effects of eighteen various detergents
on Rac1 extraction from the membrane fraction of insect cells (upper panel) and inspection of Rac1 prenylation via pull-down with GST-GDI1 (lower
panel). Membrane fractions mixed with two different concentrations (0.5% and 1%) of the respective detergents (Table S1 in File S1) were incubated
at room temperature for 30 min, separated in supernatants (S1) and pellets (P1) by centrifugation and immunoblotted using anti-Rac1 antibody. The
Supernatants S1 were used in pull-down assays (PD) by using GST-GDI1, which selectively binds to the intact, nucleotide-bound Rac1. Resulted pellets
(P2, corresponding to the GSH beads) and supernatant (S2) were visualized by anti-Rac1 antibody in immunoblots. Underlined detergents, especially
CHAPS, showed the best properties in the extraction of GDP-bound Rac1 from the insect cell membranes.
doi:10.1371/journal.pone.0102425.g001
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binding to the switch regions of active Rac1 competitively blocks
the GDI1 association with the same regions of Rac1.
We next set out to analyze Rac1Ic activation on the liposomes in
the presence and in the absence of Pak1 and GDI1. We first
prepared GDP-bound Rac1Ic associated with liposomes, which
were then incubated with free GppNHp and the DHPH domains
of the RacGEF Tiam1 to accelerate the nucleotide exchange of
Rac1Ic, leading to membrane bound Rac1Ic-GppNHp. GST-
DHPH of Tiam1 as a minimal RacGEF protein contains the
catalytic (Dbl homology or DH) and the lipid membrane binding
(pleckstrin homology or PH) domains. GST-Pak1 was mixed in the
samples as a marker for activated Rac1Ic as it selectively binds to
the active, GppNHp-bound state of Rac1 [53]. After incubation,
the mixture was spun down and GST fusion in the pellet was
visualized by immunobloting using anti-GST antibody. Results
shown in Figure 3C revealed that Pak1 could be detected
predominatantly in the liposome pellet only when both Tiam1
and GppNHp were present. In addition, DHPH was also detected
in the pellet fraction. These data clearly indicate that Tiam1
DHPH was able to activate Rac1Ic on the liposomes.
The next question we addressed was the ratio of soluble and
liposome-bound Rac1 in the presence of GDI1, the RacGEF
Tiam1 and the Rac effector Pak1. The majority of GDP-bound
Rac1 appeared in complex with GDI1 (Fig. 3D, lane 1) indicating
again that GDI1 efficiently extract Rac1Ic from the liposomes. The
picture slightly changed when the experiment was repeated also in
the presence of Pak1 and GppNHp (Fig. 3D, lane 2) or Pak1 and
Tiam1 (Fig. 3D, lane 3). There was, however, a significant
limitation of the GDI-mediated Rac1 extraction from the
liposomes observable when all components were in the sample
(Fig. 3D, lane 4). This clearly demonstrates that a Tiam1-mediated
exchange of the bound GDP for GppNHp resulted in the Rac1Ic-
GppNHp-Pak1 complex formation on the liposomes as shown by
Pak1 blotting (Fig. 3D, lane 4). This significantly blocked GDI1
association with and extraction of Rac1Ic from the liposomes. This
result suggests that Rac1 activation by Tiam1 largely counteracted
Figure 2. Nucleotide-independent extraction of Rac1Ic from the liposomes by GDI1. (A) GST-GDI1 pull-down of Rac1Ic but not of Rac1Ec.
Input is the total mixture of beads and proteins, and output is the pull-down (PD). (B) Liposome binding of Rac1Ic but not of Rac1Ec. In the liposome
sedimentation assay, Rac1Ic efficiently binds to liposomes in the absence of GDI1 and independent of whether it was loaded with GDP or GppNHp, a
non-hydrolysable GTP analog. Rac1Ec failed to bind to liposomes under the same conditions. (C) Preferential binding Rac1Ic to GDI1 than to
liposomes. GDI1 binds to both GDP-bound and GppNHp-bound Rac1Ic proteins and prevents their association with the liposomes. (D, E) GDI1
efficiently extracted GDP-bound Rac1Ic from the liposomes and to a lower extend also Rac1Ic-GppNHp. Same amount of GDP-bound and GppNHp-
bound forms of Rac1Ic associated with the liposomes were prepared before incubation with 5-fold molar excess of GDI1 and sedimentation at
20,000xg (D). Using increasing molar excess of GDI1 (2-, 5-, 10-, 15- and 20-fold) showed that higher concentrations of GDI1 are required to extract
Rac1Ic-GppNHp from the liposomes to supernatants in comparison to Rac1Ic-GDP (E). CBB, coomassie brilliant blue; Ec, E. coli; Ic, insect cells; P,
liposome pellet; S, supernatant.
doi:10.1371/journal.pone.0102425.g002
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the extraction of Rac1 from the liposomes by RhoGDI and shifts
Rac1 towards a signaling-competent state.
However, the scenario substantially changes when Rac1Ic-GDP
was not liposome-bound, like in the previous experiments, but in
the complex with GDI (Fig. 3E). Under this condition, the
presence of Tiam1, GppNHp and Pak1 was required to
significantly release Rac1Ic-GDP from its GDI complex, to
catalyze the nucleotide exchange by Tiam1 and to generate a
liposome-bound Rac1Ic-GppNHp-Pak1 complex. This result
clearly indicate that Tiam1 and Pak1 are certainly able to
quantitatively displace the Rac1-GDP-GDI complex.
Rac1Ic activation by liposome-associating RacGEFs
The RhoGEFs of the Dbl family have been commonly
implicated as lipid membrane binding modules [54]. The
experiments described above have shown that Tiam1 DHPH
activates liposome-bound Rac1, which can be atributed to the
lipid membrane-binding PH domain [27,55,56]. Recently, we
have shown that in addition to Tiam1 also Vav2, P-Rex1, Dbl,
and TrioN are Rac1-specific GEFs [11]. These experiments have
been performed under cell-free conditions in the absence of
liposomes using nonprenylated Rac1 protein. Prior to the analysis
of these Dbl proteins towards Rac1Ic, we analyzed their liposome-
binding properties using the respective GST-DHPH proteins
expressed and purified from E. coli. Therefore, we used four
different types of liposomes, synthetic liposomes comprising in
addition to PS, PC, PE and SM, either PIP2 (Lipo+PIP2) or PIP3
(Lipo+PIP3), as well liposomes derived from bovine brain type I and
III Folch membrane lipids (see Materials and Methods). Figure 4A
shows different liposome-binding capabilities of the five different
Dbl proteins. Vav2, Dbl and P-Rex1 differently bound to all types
of liposomes. TrioN and Tiam1 were hardly detected in Lipo+PIP2
but differently bound to the other liposomes. Interestingly, Tiam1
tightly bound to Folch III liposomes.
Figure 3. Pak1 binding to activated Rac1Ic counteracting its extraction from the liposomes by GDI1. (A) Pak1 interferes with GDI1
binding to GppNHp-bound Rac1Ic and potentiates Rac1Ic-GppNHp association with the liposomes. An excess amount of 20-fold of Pak1 was used in
liposome sedimentation assay. (B) Competitive inhibition of the GDI1-mediated Rac1Ic-GppNHp extraction from the liposomes by Pak1. (C) Tiam1-
mediated Rac1Ic activation on the liposomes. Liposome-bound Rac1Ic-GDP was incubated with Pak1 in the presence or absence of Tiam1-DHPH and
an excess of GppNHp. Rac1Ic activation on liposome was evaluated by detecting Pak1 in the pellet, which is bound to Tiam1-activated Rac1Ic. (D)
Tiam1-mediated Rac1Ic activation on the liposomes in the presence of GDI1. (E) Partial displacement from the GDI1 complex, activation by Tiam1 and
association of Rac1Ic with liposomes and Pak1. CBB, coomassie brilliant blue; Ec, E. coli; Ic, insect cells; P, liposome pellet; S, supernatant.
doi:10.1371/journal.pone.0102425.g003
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The capacity of the five Rac-specific Dbl proteins in the Rac1Ic
activation on the Lipo+PIP2 was next determined under the same
conditions as described above (Figs. 3C and 3D). Consistent with
their liposome binding pattern Vav2 and Dbl revealed the highest
RacGEF activities shown as largest amount of Pak1 sedimented
with activated, GppNHp-bound Rac1Ic (Fig. 4B). P-Rex1, Tiam1
and TrioN activated Rac1Ic to a lower extent (Fig. 4B), particularly
TrioN, corresponding to their liposome binding capabilities
(Fig. 4A). These data suggest that as stronger the respective Dbl
protein interact with the liposomes as higher is its accessibility to
Rac1. We next examined the capability of Vav2 and Dbl in
displacing and activating Rac1Ic from its complex with GDI1.
Therefore, we mixed Rac1Ic-GDP-GDI1 with PIP2-containing
liposomes, Pak1, GppNHp and the DHPH domains of Vav2, Dbl
or Tiam1, respectively, and conducted liposome sedimentation.
Dbl DHPH displaced and activated Rac1Ic most efficiently as
compared to Tiam1 and Vav2, which is visualized by a significant
amount of Rac1Ic-GppNHp-Pak1 complex on the liposomes
(Fig. 4C). Unexpectedly, this observation was not confirmed for
Vav2, although a considerable amount of DHPH and Pak1 was
sedimented with the liposomes (Fig. 4C). This result suggests that
Dbl and Tiam1, but however not Vav2, contribute to displace-
ment of Rac1 from the GDI complex by shifting the reaction
towards active, GTP-bound Rac1 that is prepared for effector
interaction and thus downstream signaling.
Tight Tiam1-binding to Folch III liposomes (Fig. 4A) prompted
us to determine Tiam1 GEF activity on all four types of liposomes
as we expected by far the highest Rac1Ic activation on Folch III
liposomes. Suprisingly, we obtained contrary results. In contrast to
the other liposomes, on which Rac1Ic was modestly activated by
Tiam1, Folch III did not bind Rac1Ic at all (Fig. 4D). As a
consequence, Pak1 sedimentation could not be detected, although
Tiam1 was presented on the Folch III liposomes (Fig. 4D). Folch
III has been described to contain mainly PS (80%), and minor
contents of PE (10%), cerebrosides (5%), and other unidentified
membrane lipids (5%) [46]. In fact, we expected Rac1Ic, due to the
positive electrostatics, immediately upstream of the prenylated
cysteine 189 at its very C-terminus (183KKRKRKCLLL192), to
Figure 4. Rac1Ic activation on liposomes by different Dbl family proteins and association with Pak1. (A) Differential binding of Vav2,
Dbl, TrioN, Tiam1 and P-Rex1 to various liposomes. Lipo+PIP2 is composed of PE, PC, PS, SM and PIP2. In Lipo+PIP3, PIP2 is replaced by PIP3. (B) Efficient
Rac1 activation by Dbl and Vav2 on Lipo+PIP2. (C) Displacement from the GDI1 complex, activation by GEFs and association of Rac1Ic with liposomes
and Pak1. (D) Tiam1 but not Rac1Ic binding to Folch III. Rac1GDP, Pak1, Tiam1, GppNHp and different liposomes were preincubated, afterwards the
liposome sedimentation assay was conducted. Rac1, PAKa and Tiam1 from the liposome pellet were detected by GST antibody. (E) Rac1Ic repulsion
by PC but not PS. Liposomes (PS and PE or PC and PE) at increasing amounts of PS and PC were sedimented after incubation with Rac1Ic. (F) Thin layer
chromatography of Folch I and Folch III liposomes. Relative lipid content of Folch I and Folch III liposomes was analyzed by thin layer
chromatography. PE, PS and PC as well as Folch III containing PS and PS were used as controls. CBB, coomassie brilliant blue; Ec, E. coli; Ic, insect cells;
P, liposome pellet; S, supernatant.
doi:10.1371/journal.pone.0102425.g004
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bind tightly to the abundant, negatively charged PS moiety present
in Folch III. However, synthetic liposomes and liposomes
composed of Folch I also contain 50% PS (see Materials and
Methods). Thus, we tested the effect of increasing PS concentra-
tions in synthetic liposomes on the Rac1Ic binding and used PC as
a control. Interestingly, not increasing PS concentrations but PC
repelled Rac1Ic from associating with the liposomes (Fig. 4E)
clearly supporting the existence of both an electrostatic attraction
in the effective potential between Rac1Ic and PS-containing
liposomes and an electrostatic repulsion in the case of PC-
containing liposomes. These data also suggest that Folch III may
contain a different material that repel Rac1Ic from the liposomes,
which cannot be PS. Therefore, we analyzed the content of our
liposomes by conducting a thin layer chromatography. Data
shown in Figure 4F revealed Folch III indeed contains PS and not
PC. There is a trace of lipids that are less polar than PS, which
may be the cause for the Rac1Ic repulsion. These data strongly
suggest that Rac1 association with the membranes depends in
addition to isoprenylation and accessory proteins also on local lipid
composition.
Discussion
The cell membrane is a platform for signal transduction through
transmembrane receptors and membrane-associated proteins,
including heterotrimeric G proteins and small GTPases of the
Ras superfamily. These proteins are essentially dependent on
posttranslational modifications by isoprenylation, palmitoylation
or myristoylation to achieve their function [57,58,59]. In addition
to studies of structural and chemical aspects of the individual
proteins and components of signaling pathways, the new challenge
is to investigate the influence of the lipid membrane surface
environment on the temporal and spatial regulation of signaling
events. One approach is the in vitro liposome reconstitution using
purified proteins and synthetic liposomes. To this end prenylated
GTPases are purified from tissues, eukaryotic cells, such as yeast,
or they are synthesized by chemical ligation of unmodified
GTPases from E. coli with a synthetic peptide harboring an
isoprenyl moiety [36]. In this study, we used the baculovirus-insect
cell expression system to express and purify recombinant human
Rac1 in a prenylated form. This system has the advantage to
express recombinant genes from any origin and produce
considerable amounts of modified proteins [60]. Purification of
postranslationally modified GTPases, such as prenylated Rac1, is
challenging in a way that its native, nucelotide-bound form needs
to be maintained if extracted from the cell membranes. In a
comprehensive detergent screen we found that some detergents,
e.g. CHAPS, quantitatively extracted human Rac1-GDP from the
insect cell membranes as monitored by a RhoGDI pull-down
assay. Mass spectrometry, liposome- and RhoGDI-binding
revealed that human Rac1 purified form insect cells is, in contrast
to that purified from E. coli, posttranslationally modified.
Similar to our data, GDI1 has been reported previously to bind
to and extract both nucleotide-bound forms of Cdc42 from plasma
membranes in vitro [23,24]. Robbe and colleagues have shown
that purified GDP-bound Rac1 from insect cells was dissociated
from its complex with RhoGDI and associated with liposomes
when the bound GDP was exchanged for GTP by depleting the
bound Mg2+ by EDTA treatment [27]. Fewer studies were
conducted by using prenylated Rac1 protein alone to elucidate its
interaction with GDI1 and the liposomes: It has been shown that
Rac1 purified from insect cell membrane fractions interact with
artificial phagocyte membranes and that GDI1 counteracted this
process [61]. This regulatory process is visualized in the present
study in a direct way. We showed that GDI1 preferentially
associates with the inactive, GDP-bound Rac1 and displaces it
from the membrane as reported previously [50]. In addition, we
found that a displacement of the active Rac1-GppNHp is also
possible in spite of its low affinity for the GDI1. However, this does
not take place if a Rac1 effector is in the proximity, as we showed
for PAK1.
We have shown above that GDI1 also binds Rac1-GppNHp,
consistent with early reports [62], and extracts it from the
liposomes, although not as efficiently as Rac1-GDP (Fig. 2). One
reason is that only a few residues of the four regions on Rac1
(amino acids or aa 29–42 of switch I, aa 62–68 of switch II, aa 91–
108 of a-helix 3 and aa 187–189 at the C-terminus), which are in
direct contact with GDI [3], determine the specificity of the
interaction of Rac-GDP with GDI [28,63]. Interestingly, con-
served residues, such as Val36 and Asp38 of switch I, and Arg68,
Tyr66, Leu69 and Leu72 of switch II, do not only contribute to
the interaction with the GDI, but also to the interaction with
GAPs and effectors. Under this environmental condition on the
surface of the plasma membrane GDI does probably not undergo
any interaction with Rac1-GTP because it, as long as it is not
switched off by GAPs, may preferentially exist in complex with
various signal-transducing effectors, such as Pak1 [18,20,64]. This
is exactly what we observed in this study when we mixed Rac1-
GppNHp bound to liposomes with both GDI1 and Pak1. The
latter binds Rac1 and blocks both, the accessibility of GDI1 and
consequently Rac1-GppNHp extraction from the liposomes
(Fig. 3B). As a downstream effector of Rac1, Pak1 and its GBD
specifically and tightly bind to activated Rac1 [53,65,66,67]. Based
on these findings, we can propose that RhoGDIs may also displace
GTP-bound Rho GTPases from the plasma membrane presuming
there are no Rac-specific effectors or GAPs around.
Another issue to be discussed is the interrelationship between
GDIs and GEFs in regulating members of the Rho family. Unlike
three known human RhoGDIs [15,16], the classical Dbl GEF
family consists of 74 members in human [11]. They are
characterized by a unique, catalytic DH domain often preceded
by a pleckstrin homology (PH) domain indicating an essential and
conserved function [11,12,54]. The PH domain has been
implicated to serve multiple roles in signaling events anchoring
GEFs to the membrane (e.g. via phosphoinositides) [54] and
directing them towards their interacting GTPases which are
already localized to the membrane [12]. In this regard, it is
important to note that the bulk of the added GEFs remained in the
soluble fraction in the presence of liposomes (Fig. 4A), which most
likely is, except for Vav2 and Dbl, due to low binding affinity of
the tandem PH domain for the lipid membrane. This clearly
suggests that the GEF recruitment to the cell membrane underlays
additional concerted mechanisms. One is that accessory binding
domains, existing in some GEFs, may be necessary to promote
membrane association. This includes an extra PH domain, e.g. in
Tiam1 [68], a diacylglycerol binding C1 (protein kinase C
conserved region 1) domain, e.g. in Vav proteins [69], or a
Sec14 domain, e.g. in Dbl [70]. The other membrane-translocat-
ing mechanism involves adaptor proteins, such the G protein bc
subunits recruiting P-Rex1 [71] or the Arp2/3 complex recruiting
Tiam1 [72,73].
Moreover, we found that dissociation of Rac1-GDP from its
complex with GDI1 strongly correlated with two distinct activities
of the DHPH of especially Dbl and Tiam1, including PH-
mediated association with liposomes and DH-mediated GDP/
GppNHp exchange of Rac1 (Figs. 3E and 4C). This and the fact
that the binding affinity of the DH domain for the GDP-bound
Rho GTPase is in the lower micromolar range (Z. Guo, E. Amin,
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R. Dvorsky and M.R. Ahmadian, unpublished data) indicates that
the Rho GTPase-GDI complex may not be as tight as it has been
suggested previousely [17,24]. However, future investigations will
elucidate the displacement of Rac1 from the GDI complex in the
presence of liposomes and RacGEFs, both of which participate in
the mechanism of specific activation of Rac1 and are required for
accurate downstream signaling. This study has just opened a new
window into future mechanistic studies of Rac1 regulation and
signaling.
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